Home > SWOT Analysis > Idera Pharma (IDRA) SWOT Analysis




Idera Pharma (IDRA) SWOT Analysis Profile

Idera Pharmaceuticals, Inc., founded in 1989, discovers and develops DNA- and RNA-based biotechnology compounds for the treatment of disease. The companys proprietary Toll-Like Receptors modulate immune responses. Their research involves treatments for such diseases as cancer, Alzheimers, lupus, asthma, and a variety of infectious diseases. Idera Pharmaceuticals is based in Cambridge, Massachusetts. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email